season
epidem
circul
influenza
influenza
b
human
respiratori
syncyti
viru
rsv
virus
caus
larg
part
burden
viral
respiratori
infect
northern
hemispher
especi
involv
infant
week
age
elderli
patient
simo
neuzil
et
al
simonsen
et
al
poehl
et
al
nair
et
al
rapid
identif
viral
caus
acut
respiratori
infect
consequ
patient
monitor
care
includ
hospit
admiss
discharg
administr
antibiot
antivir
therapi
reduct
diagnosi
investig
adcock
et
al
barenfang
et
al
antigen
detect
immunofluoresc
immunochromatographi
usual
diagnost
approach
although
lack
sensit
steining
et
al
louie
et
al
altern
test
viral
genom
molecular
mean
although
variou
commerci
assay
avail
molecular
detect
rare
routin
practic
either
high
cost
commerci
assay
assay
multiplex
short
turnaround
time
et
al
gunson
et
al
kuyper
et
al
bonroy
et
al
van
de
pol
et
al
et
al
studi
simpl
sensit
specif
triplex
assay
develop
detect
genom
rsv
influenza
includ
pandem
influenza
viru
influenza
b
simultan
respiratori
sampl
assay
perform
daili
season
two
independ
laboratori
sampl
adult
children
test
compar
identif
viral
infect
rapid
accur
allow
improv
manag
patient
present
acut
respiratori
infect
variou
influenza
influenza
b
rsvab
strain
use
determin
sensit
effici
assay
tabl
genotyp
genotyp
isol
clinic
specimen
collect
caen
franc
test
rsv
genotyp
determin
phylogenet
analysi
g
gene
accord
protocol
establish
nation
paramyxovirida
centr
av
ff
unpublish
data
use
primer
describ
previous
zambon
et
al
virus
propag
cell
cultur
mdck
influenza
influenza
b
rsv
viru
titer
report
plaqu
form
unit
pfu
influenza
b
tissu
cultur
infecti
dose
ml
rsv
undilut
cultur
supernat
adenoviru
echoviru
rhinoviru
coronaviru
use
assess
specif
assay
specimen
nasopharyng
aspir
swab
collect
patient
acut
respiratori
infect
syndrom
test
daili
either
ambrois
gener
teach
hospit
trousseau
pediatr
teach
hospit
rna
extract
qiaamp
qiagen
courtaboeuf
franc
fresh
thaw
specimen
aliquot
result
rna
prepar
elut
includ
mixtur
contain
primer
probe
tabl
ii
master
mix
reagent
kit
applera
courtaboeuf
franc
run
includ
neg
control
triplex
posit
control
posit
control
contain
target
rna
extract
cultur
supernat
dilut
give
posit
signal
ct
correspond
input
approxim
pfu
influenza
b
rsv
tabl
reaction
consist
min
min
activ
cycl
amplif
sec
sec
fast
pcr
system
applera
use
reaction
give
ct
valu
consid
posit
test
perform
freshli
sampl
nasopharyng
aspir
b
monoclon
antibodi
argen
sa
verniol
franc
use
recommend
manufactur
primer
probe
argen
sa
assay
use
two
independ
target
either
influenza
ab
aliquot
rna
prepar
see
procedur
ad
two
mixtur
contain
primer
probe
onestep
mix
qiagen
intern
control
dico
extra
argen
sa
ad
sampl
prior
extract
monitor
extract
step
detect
pcr
inhibitor
addit
mixtur
contain
rna
extract
dico
extra
premix
onestep
mix
qiagen
prepar
cycl
condit
recommend
argen
sampl
use
inocul
mdck
influenza
virus
detect
hemagglutin
assay
erythrocyt
isol
subtyp
determin
previous
describ
kendal
et
al
assay
use
character
pandem
influenza
virus
follow
protocol
establish
nation
influenza
centr
northern
franc
http
nonparametr
use
statist
comparison
differ
consid
signific
p
valu
specif
triplex
assay
confirm
neg
result
obtain
viral
genom
respiratori
virus
triplex
posit
control
gave
repeatedli
posit
signal
three
virus
target
observ
triplex
assay
test
individu
control
influenza
influenza
b
rsv
genom
sensit
assay
vari
accord
strain
pfuinput
influenza
virus
rsv
tabl
abil
triplex
assay
detect
viral
genom
nasopharyng
sampl
assess
select
panel
sampl
collect
test
store
sampl
test
triplex
assay
commerci
flu
ab
rsv
ab
assay
dico
extra
control
use
detect
pcr
inhibitor
sampl
posit
n
influenza
n
influenza
b
n
rsv
n
found
posit
respect
virus
molecular
test
furthermor
sampl
posit
assay
concord
two
test
posit
influenza
seven
influenza
b
rsv
pcr
inhibitor
detect
variou
result
indic
abil
triplex
assay
detect
viral
genom
similar
individu
assay
assay
initi
design
detect
current
epidem
viral
strain
thu
sensit
pandem
strain
emerg
clinic
isol
posit
viru
assay
provid
influenza
nation
refer
centr
sampl
posit
triplex
assay
rang
ct
similar
sampl
posit
epidem
strain
week
sampl
routin
collect
patient
ambrois
test
triplex
assay
genom
influenza
influenza
b
rsv
tabl
iii
tempor
distribut
viru
detect
shown
figur
patient
test
posit
rsv
influenza
one
rsv
influenza
influenza
b
infect
detect
period
influenza
isol
subsequ
perform
sampl
correspond
epidem
strain
current
time
posit
isol
significantli
correl
viral
load
specimen
viral
load
estim
ct
valu
posit
specimen
median
ct
valu
wherea
neg
specimen
p
period
week
character
pandem
circul
influenza
week
test
also
use
trousseau
laboratori
tabl
iii
patient
adult
children
test
ambrois
posit
rsv
influenza
one
rsv
influenza
fig
patient
children
test
trousseau
posit
rsv
influenza
mix
infect
fig
influenza
genom
detect
character
assay
viru
influenza
b
infect
detect
period
detect
rsv
infect
infant
week
old
present
medic
condit
prematur
underli
cardiopulmonari
diseas
lead
hospit
admiss
monitor
risk
rapid
respiratori
aggrav
apnea
hall
tregon
schwarz
also
children
influenza
often
present
alarm
neurolog
symptom
associ
respiratori
diseas
need
neurolog
investig
influenza
viru
detect
rapidli
similarli
viral
infect
diagnos
newborn
isol
fever
investig
neonat
bacteri
infect
limit
moreov
earli
administr
neuraminidas
inhibitor
case
influenza
may
prevent
sever
form
infect
report
influenza
pandem
c
final
rsv
influenza
virus
epidem
rate
case
may
possibl
distinguish
infect
one
viru
basi
clinic
present
bosi
et
al
bourgeoi
et
al
thu
rapid
sensit
tool
need
specif
detect
influenza
rsv
infect
identifi
mix
infect
diagnost
valu
rapid
antigen
detect
test
influenza
rsv
infect
remain
subject
debat
although
technic
well
adapt
manag
acut
respiratori
infect
current
avail
test
lack
sensit
specif
steining
et
al
louie
et
al
aim
studi
improv
effici
diagnosi
acut
respiratori
infect
context
high
rate
infect
three
major
pathogen
involv
mix
infect
higher
sensit
compar
antigen
detect
prompt
us
use
technolog
develop
inexpens
rapid
hr
specif
sensit
assay
target
genom
influenza
influenza
b
rsv
triplex
cheaper
faster
three
simplex
assay
facilit
use
daili
practic
procedur
simplifi
adapt
extract
step
magna
pure
compact
system
roch
diagnost
meylan
franc
assay
success
transfer
differ
laboratori
set
differ
pcr
thermocycl
use
abi
real
time
pcr
system
applera
although
compar
rapid
antigen
test
assay
effici
enough
provid
clinician
specif
sensit
result
daili
sampl
made
avail
result
return
assay
design
detect
simultan
presenc
three
viral
genom
could
thu
identifi
mix
infect
abil
detect
variou
strain
virus
assess
panel
virus
isol
panel
sensit
effici
triplex
found
slightli
lower
obtain
equival
simplex
assay
although
differ
signific
result
shown
previous
report
other
multiplex
bonroy
et
al
howev
sensit
effici
assay
suitabl
diagnosi
inde
result
concord
sampl
found
posit
commerci
assay
triplex
assay
success
detect
mix
infect
thermocycl
allow
three
differ
fluoresc
dye
pcr
assay
triplex
assay
could
also
includ
intern
control
howev
pcr
inhibitor
detect
sampl
test
argen
method
indic
risk
miss
posit
sampl
small
necessari
routin
diagnosi
intern
control
could
ad
sampl
prior
extract
correspond
control
could
perform
parallel
run
result
obtain
assay
daili
practic
season
consist
data
provid
nation
network
gp
pediatrician
grog
group
dobserv
de
la
gripp
region
influenza
surveil
group
http
wwwgrogorg
nation
influenza
centr
northern
franc
indic
particular
circul
influenza
b
sporad
absent
franc
period
studi
previous
describ
bourgeoi
et
al
rsv
infect
frequent
influenza
young
children
evidenc
higher
percentag
specimen
even
influenza
pandem
final
avail
molecular
tool
allow
distinguish
rapidli
influenza
rsv
two
gener
hospit
set
context
influenza
pandem
utmost
valu
conclus
triplex
report
effici
test
nasopharyng
specimen
current
epidem
strain
influenza
includ
season
predomin
vaux
season
season
pandem
influenza
influenza
b
abil
detect
mix
infect
also
facilit
investig
increas
knowledg
incid
sever
influenza
rsv
kehl
et
al
coira
et
al
clinic
data
collect
nasopharyng
sampl
respiratori
viru
test
part
current
manag
patient
acut
respiratori
infect
ill
ethic
approv
requir
studi
